Introduction: Limited cross-sectional or case–control studies have identified the relationship between basilar artery (BA) curvature and posterior circulation infarction (PCI). This study aimed to identify the influence of BA curvature severity on the risk of PCI occurrence in patients without vertebrobasilar stenosis through a prospective cohort study. Methods: In this study, we enrolled 171 patients with BA dolichosis but without vertebrobasilar stenosis. The BA geometric parameters were evaluated on MRA. The primary outcome was the occurrence of PCI, mainly referring to cerebellar and/or brainstem infarction. Cox proportional hazard models were used to detect possible predictors of PCI. Results: Among them, 134 (78.4%) patients were diagnosed with BA curvature, including 124 with moderate curvature and 10 with prominent curvature. The defined PCI occurrence was observed in 32 (18.7%) patients with a median follow-up time of 45.6 months. Cox proportional hazard analysis showed that BA prominent curvature (HR = 6.09; 95% CI: 1.36–27.28; P = 0.018) significantly increased the risk of PCI occurrence, and bending length (BL) was also significantly associated with PCI occurrence, with the adjusted HR per 1-mm increase of BL of 1.09 (95% CI: 1.01–1.18; P = 0.040). In the subgroup analysis stratified by age, BA prominent curvature was highly associated with PCI occurrence in patients aged > 61 years (HR = 11.76; 95% CI: 1.21–113.90; P = 0.033). Additionally, good antiplatelet therapy adherence could significantly reduce the risk of PCI occurrence. Conclusion: BA curvature may increase the risk of PCI occurrence, especially in elderly patients with prominent curvature. Improving adherence to antiplatelet therapy can help reduce the risk of PCI occurrence.
16 January 2023 in Multiple Sclerosis and Related Disorders
Objective: This study aims to explore the frequency and influencing factors of asymptomatic spinal lesions (ASLs) and their impact on subsequent relapses in patients with AQP4‐IgG‐positive NMOSD (AQP4‐NMOSD) in a real‐world setting.Methods: We retrospectively reviewed clinical information and spinal MRI data from AQP4‐NMOSD patients who had at least one spinal cord MRI during their follow‐ups. Kaplan–Meier curves and Cox proportional hazards models were employed to ascertain potential predictors of remission ASLs and to investigate factors associated with subsequent relapses.Results: In this study, we included 129 patients with AQP4‐NMOSD and reviewed 173 spinal MRIs during attacks and 89 spinal MRIs during remission. Among these, 6 ASLs (3.5%) were identified during acute attacks, while 8 ASLs (9%) were found during remission. Remission ASLs were linked to the use of immunosuppressive agents, particularly conventional ones, whereas no patients using rituximab developed ASLs (p = 0.005). Kaplan–Meier curve analysis indicated that patients with ASLs had a significantly higher relapse risk (HR = 4.658, 95% CI: 1.519–14.285, p = 0.007) compared to those without. Additionally, the use of mycophenolate mofetil (HR = 0.027, 95% CI: 0.003–0.260, p = 0.002) and rituximab (HR = 0.035, 95% CI: 0.006–0.203, p < 0.001) significantly reduced the relapse risk. However, after accounting for other factors, the presence of ASLs did not exhibit a significant impact on subsequent relapses (HR = 2.297, 95% CI: 0.652–8.085, p = 0.195).Interpretation: ASLs may be observed in patients with AQP4‐NMOSD. The presence of ASLs may signify an underlying inflammatory activity due to insufficient immunotherapy. The administration of immunosuppressive agents plays a key role in the presence of remission ASLs and the likelihood of subsequent relapses.
24 November 2020 in Journal of International Medical Research
Anton’s syndrome is a rare neuropsychiatric syndrome that is characterized by cortical blindness and anosognosia with visual confabulation, but without global cognitive impairment. We herein report a rare case of Anton’s syndrome as a presentation of Trousseau syndrome involving the bilateral optic radiation. The patient had been diagnosed with gallbladder cancer 2 months previously, and he was admitted to the hospital with confusion and quadriplegia. He was found to be blind, but denied any visual impairment and demonstrated visual confabulation despite evidence of his blindness. These signs were consistent with a diagnosis of Anton’s syndrome. Brain computed tomography (CT) and magnetic resonance imaging revealed infarcts in the bilateral temporo-parieto-occipital junction with hemorrhagic transformation, mainly involving the bilateral optic radiation. The presence of gallbladder cancer with peripheral metastasis on abdominal CT, as well as markedly increased tumor markers and D-dimer levels, supported the presence of cancer-related hypercoagulability and the diagnosis of Trousseau syndrome.
Background and purpose: White matter hyperintensities (WMH) are a common imaging manifestation of cerebral small vessel disease (CSVD). While carotid intraplaque neovascularization (IPN) has been implicated in WMH burden, its longitudinal impact on WMH progression, particularly across different brain regions, remains to be fully elucidated. Methods: We conducted a longitudinal cohort study of patients with baseline WMH, who underwent carotid IPN grading (Grade 0–2) via AngioPLUS ultrasound. Clinical demographics, vascular risk factors, and key laboratory parameters (including homocysteine and LDL-C) were collected. WMH progression was defined as an increase in the total score of the visual Rotterdam Progression Scale (range: −7 to +7) by ≥1 point on follow-up MRI, indicating new or enlarged lesions. Logistic regression analysis was used to determine the relationship between IPN and progression of white matter hyperintensities. Results: In this longitudinal cohort study, a total of 213 patients (mean age 71.0 ± 8.9 years; 56.8% male) were included in the final analysis. Over a mean follow-up period of 17.8 months (range: 4–52 months), overall progression of white matter hyperintensities (WMH) was observed in 124 patients (58.2%). Specifically, progression of periventricular WMH (PWMH) and deep WMH (DWMH) occurred in 42.3 and 33.8% of patients, respectively. Patients with WMH progression showed a significantly higher prevalence of vascular risk factors compared to those without progression. Logistic regression analysis, after adjustment for age, smoking, alcohol consumption, hypertension, diabetes, history of stroke, body mass index, low-density lipoprotein cholesterol, and follow-up duration, indicated that grade 2 (high-grade) intraplaque neovascularization in the carotid artery was independently associated with the progression of deep white matter hyperintensities (OR 2.06, 95% CI 1.05–4.05). Conclusion: Carotid intraplaque neovascularization is an independent predictor of deep WMH progression. Assessing plaque vulnerability via IPN grading may help identify patients at high risk for progressive white matter injury and serve as a potential target for therapeutic intervention.